Explore a vendor showcase presentation from the 2022 Cancer Genomics Consortium Annual Meeting that delves into internalizing a comprehensive genomic profiling solution with a path to reimbursement. Learn about the challenges faced in cancer genomics, including peer pressure and patient burden, and discover why PGDX was chosen as a solution. Gain insights into the approval process, workflow implementation, and reimbursement strategies. Examine a lab snapshot and summary of the presented information, providing valuable knowledge for professionals in the field of clinical cancer genomics.
Internalizing a Comprehensive Genomic Profiling Solution with a Path to Reimbursement
Cancer Genomics Consortium via YouTube
Overview
Syllabus
Introduction
Agenda
Mikes Story
Challenges
Peer Pressure
Patient Burden
Why PGDX
Getting Approved
PGDXLU
Workflow
Reimbursement
Lab Snapshot
Summary
Ishaan
Taught by
Cancer Genomics Consortium
Related Courses
-
Clinical, Cytogenetic and Genomic Profiling of B-Other Acute Lymphoblastic Leukemia - An Indian Cohort Study
-
Developing Next Generation Biomarkers - A New Approach
-
Genetic Ancestry, Somatic Alteration and Outcome in Cancer Genomics - Invited Presentation
-
Genetic Spectrum of RAS Alterations - A Highlight of In-Frame Insertion Variants in Association with Vascular Anomalies
-
ClinGen Cancer Variant Interpretation Committee - Pilot Guidance for Somatic Cancer Variant Curation
-
Fusion Curation Interface: An Educational Tool to Explore a Unified Framework
